Delivery Order SPE2DR25D1103-SPE2DR26FE337
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100 count) with a ceiling value of $2,501.99. This competitive, non-set-aside award was executed on September 11, 2025, with an ultimate completion date of September 12, 2025. The delivery order utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,246.14 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100-count units) on December 9, 2025, with completion scheduled for December 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100-count packaging) with a ceiling value of $1,426.55. This competitive award, issued on November 4, 2025, with an ultimate completion date of November 5, 2025, represents a firm fixed-price delivery order under a larger contract vehicle. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. No set-aside designation was...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $1,519.52. The order was competitively awarded on December 10, 2025, with an ultimate completion date of December 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This firm fixed-price delivery order represents a small-value pharmaceutical transaction...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Methylphenidate ER 36 mg tablets in quantities of 100, with a contract ceiling value of $1,224.06. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of October 31, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100 count) with a ceiling value of $1,178.10. The award, issued on September 23, 2025, is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025. The contract utilizes no set-aside designation and was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count) with a contract value of $2,307.76. This is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100-count) on September 25, 2025, with a ceiling value of $2,161.83 and an ultimate completion date of September 26, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed price terms and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The work will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $3,150.33. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award under the federal pharmaceutical procurement process. The order is scheduled for completion by August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,073.04 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100-count units). This order, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a firm fixed-price, competitively awarded contract with no set-aside designation. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FE337Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100-count) on December 12, 2025, with a ceiling value of $1,108.44 and an ultimate completion date of December 15, 2025. This firm fixed price, non-set-aside competitive award represents a small-value delivery order under AmerisourceBergen's broader pharmaceutical supply arrangements. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where the vendor maintains its corporate operations. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide array of medications, medical supplies, and specialized healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates its significant role as a critical pharmaceutical distributor for the Defense Health Agency and other federal healthcare systems, with the company consistently winning competitive awards across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/11/25 |